NYC startup
fromFortune
5 hours agoCEO of Ozempic prescription startup Calibrate steps down as investors eye 'rapid downsizing' of consumer business | Fortune
Isabelle Kenyon stepped down as CEO and Calibrate executives were promoted to run day-to-day operations while investors restructure management.